Clinical Trial Update: Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pazopanib to reverse hormone resistance in advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Hope Rugo, MD | Conditions: Breast Cancer, Breast Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2020-06-16